The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2015

Filed:

May. 16, 2012
Applicants:

David M. Goldstein, Redwood City, CA (US);

Kenneth Albert Brameld, Menlo Park, CA (US);

Erik Verner, Belmont, CA (US);

Inventors:

David M. Goldstein, Redwood City, CA (US);

Kenneth Albert Brameld, Menlo Park, CA (US);

Erik Verner, Belmont, CA (US);

Assignee:

PRINCIPIA BIOPHARMA, INC., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 45/06 (2006.01); A61K 31/4985 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/4985 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01);
Abstract

The present disclosure provides compounds and pharmaceutically acceptable salts that are tyrosine kinase inhibitors, in particular BLK, BMX, EGFR, HER2, HER4, ITK, JAK3, TEC, Btk, and TXK and are therefore useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer and inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and pharmaceutically acceptable salts and processes for preparing such compounds and pharmaceutically acceptable salts.


Find Patent Forward Citations

Loading…